Ovid Therapeutics (OVID) Revenue (2020 - 2026)
Ovid Therapeutics (OVID) posted Revenue of $733,000 for Q2 2026, down 88.3% from $6.27 million a year earlier.
Powered by 
Analysis
Ovid Therapeutics (OVID) Revenue (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Revenue at Ovid Therapeutics was $1.58 million, down 76.2% year-over-year; for FY2025, it was $7.25 million.
- Annual Revenue shows a five-year compound annual growth rate of -10.5% (FY2020 to FY2025).
- In prior years, Ovid Therapeutics' Revenue was $566,000 in FY2024 (+44.4%), $392,000 in FY2023 (-73.9%), $1.5 million in FY2022 (-99.3%) and $208.38 million in FY2021.
- Quarterly Revenue has run from a low of $11,102 in Q3 2022 to a high of $6.27 million in Q2 2025 over five years.
- On a year-over-year basis, Revenue increased in two of the last six quarters, with growth averaging 122.1%.
- The strongest year-over-year quarter for Revenue in the past five years was Q3 2023, with growth of 881.8%; the weakest was Q1 2022, with a decline of 99.3%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Ovid Therapeutics | 460.04 Mn | 92.06 Mn | - | 733,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 733,000.00 |
| Dec 31, 2025 | 718,000.00 |
| Sep 30, 2025 | 132,000.00 |
| Jun 30, 2025 | 6.27 Mn |
| Mar 31, 2025 | 130,000.00 |
| Dec 31, 2024 | 76,000.00 |
| Sep 30, 2024 | 173,000.00 |
| Jun 30, 2024 | 169,000.00 |
| Mar 31, 2024 | 148,000.00 |
| Dec 31, 2023 | 142,000.00 |
| Sep 30, 2023 | 109,000.00 |
| Jun 30, 2023 | 75,000.00 |
| Mar 31, 2023 | 66,000.00 |
| Dec 31, 2022 | 46,280.00 |
| Sep 30, 2022 | 11,102.00 |
| Mar 31, 2022 | 1.45 Mn |
| Mar 31, 2021 | 208.38 Mn |
| Dec 31, 2020 | 5.70 Mn |
| Sep 30, 2020 | 6.91 Mn |
API Access
Ovid Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=OVID&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "OVID", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=OVID&period=max&api_key=YOUR_API_KEY");
const data = await res.json();